Cargando…

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants: randomized, observer-masked, single-center clinical study

ABSTRACT: The aim of this study is to further investigate the immune response of the inactivated split-virion vaccine for infants. We tested the immunogenicity and safety of the inactivated split-virion vaccine in infants, aged 6–35 months, for a randomized, observer-masked, age-stratified clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shilei, Dong, Jinrong, Chai, Wenqing, Li, Fangjun, Wang, Shuqiao, Sun, Bing, Chen, Ze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125604/ https://www.ncbi.nlm.nih.gov/pubmed/25110632 http://dx.doi.org/10.1186/2193-1801-3-397

Ejemplares similares

Immunogenicity and Reactogenicity of 2009 Influenza A (H1N1) Inactivated Monovalent Non-Adjuvanted Vaccine in Elderly and Immunocompromised Patients
por: Miraglia, João L., et al.
Publicado: (2011)

Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination
por: Ohfuji, Satoko, et al.
Publicado: (2011)

Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials
por: Mallory, Raburn M., et al.
Publicado: (2010)

Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double‐blind, controlled phase I clinical trial
por: Li, Yan‐Ping, et al.
Publicado: (2012)

Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens
por: Mi, Kai, et al.
Publicado: (2017)

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11
por: Ng, Sophia, et al.
Publicado: (2011)

Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients
por: Pitt, Tracy, et al.
Publicado: (2011)

Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants
por: Chilengi, R., et al.
Publicado: (2021)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

Adverse Events Following Pandemic A (H1N1) 2009 Monovalent Vaccines in Pregnant Women — Taiwan, November 2009–August 2010
por: Huang, Wan-Ting, et al.
Publicado: (2011)

Seroprevalence of Pandemic H1N1 Antibody among Health Care Workers in Hong Kong Following Receipt of Monovalent 2009 H1N1 Influenza Vaccine
por: Zhou, Ying, et al.
Publicado: (2011)

Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen
por: Sakhatskyy, Pavlo, et al.
Publicado: (2006)

Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
por: Manzoli, Lamberto, et al.
Publicado: (2011)

Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study
por: Huang, Wan-Ting, et al.
Publicado: (2013)

CD4(+) T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine
por: Nayak, Jennifer L., et al.
Publicado: (2013)

Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009–2010 season in Japan: A case-control study
por: Kondo, Kyoko, et al.
Publicado: (2015)

Assessing the immunogenicity of an inactivated monovalent vaccine in the endangered African wild dog (Lycaon pictus)
por: Anderson, Nicole, et al.
Publicado: (2019)

Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial
por: Wood, Nicholas, et al.
Publicado: (2018)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
por: Kim, Seung Youn, et al.
Publicado: (2012)

Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines
por: Woo, Jennifer C., et al.
Publicado: (2009)

Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic
por: Ito, Hiroko, et al.
Publicado: (2020)

Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice
por: Liu, Ge, et al.
Publicado: (2011)

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta‐analysis
por: Yin, J. Kevin, et al.
Publicado: (2011)

Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine
por: Weinberg, Adriana, et al.
Publicado: (2015)

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2012)

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old
por: Keitel, Wendy A., et al.
Publicado: (2015)

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
por: Herrera, Ma Teresa, et al.
Publicado: (2013)

Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus
por: Di Mario, Giuseppina, et al.
Publicado: (2017)

Effect of monovalency on anti-contactin-1 IgG4
por: Taieb, Guillaume, et al.
Publicado: (2023)

Influenza A/H1N1 2009 Pandemic and Respiratory Virus Infections, Beijing, 2009–2010
por: Yang, Yaowu, et al.
Publicado: (2012)

Protection by Face Masks against Influenza A(H1N1)pdm09 Virus on Trans-Pacific Passenger Aircraft, 2009
por: Zhang, Lijie, et al.
Publicado: (2013)

Monovalent lanthanide(I) in borozene complexes
por: Li, Wan-Lu, et al.
Publicado: (2021)

Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin
por: Peng, Bo, et al.
Publicado: (2017)

ImmunogenIcity of thE PandemRIX A (H1N1) 2009 Influenza vaccine in hemodialysed and renal transplanted patients
por: Hombrouck, A, et al.
Publicado: (2011)

Pandemic (H1N1) 2009 influenza
por: Patel, M, et al.
Publicado: (2010)

A SEROLOGIC RECAPITULATION OF PAST EXPERIENCES WITH INFLUENZA A; ANTIBODY RESPONSE TO MONOVALENT VACCINE
por: Davenport, Fred M., et al.
Publicado: (1956)

The Crystal Structure of Monovalent Streptavidin
por: Zhang, Min, et al.
Publicado: (2016)

Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine
por: Duan, Yueqiang, et al.
Publicado: (2014)

Infections with A(H1N1)2009 Influenza Virus in Poland During the Last Pandemic: Experience of the National Influenza Center
por: Romanowska, M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ltpb4iq7n6kausvg4rru8afun2